Sign in

CIK 0001645469

  • Non-accelerated filer
  • Smaller reporting company

Monopar Therapeutics

Sign in to watch
Ticker
MNPR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
320463781
Phone
+1 847-388-0349
Business address
1000 SKOKIE BLVD SUITE 350, WILMETTE, IL, 60091
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$5,335,315
in 9 filings, $5.3M under 10b5-1 plans

Net −$5,335,315. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2018-12-30 RIOUX PATRICE Acting Chief Medical Officer Grant or award · Stock option +20,000 20,000
2018-08-28 Tsuchimoto Kim R Chief Financial Officer Grant or award · Stock options +41,100 41,100
2018-08-28 Tsuchimoto Kim R Chief Financial Officer Grant or award · Stock options +41,100 85,620
2018-08-09 Anderson Raymond Director Grant or award · Stock options +26,100 26,100
2018-08-09 Brown Michael J Director Grant or award · Stock options +26,100 26,100
2018-08-09 KLAUSNER ARTHUR J Director Grant or award · Stock options +26,100 26,100
2018-08-09 STARR CHRISTOPHER M Director Grant or award · Stock options +26,100 26,100
2018-08-09 Robinson Chandler Chief Executive Officer Grant or award · Stock options +145,500 145,500
2018-08-09 Mazar Andrew Paul Chief Scientific Officer Grant or award · Stock options +134,300 134,300

Page 28 of 28 · 549 trades